Mechanized Lp(a) method as marker for coronary artery disease (CAD) illustrates the importance of very high Lp(a) levels.

被引:0
|
作者
Levinson, SS [1 ]
Kaplan, IV [1 ]
Hobbs, GA [1 ]
机构
[1] Univ Louisville, Dept Pathol, VAMC, Lab Serv, Louisville, KY 40292 USA
关键词
D O I
暂无
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
315
引用
收藏
页码:A73 / A73
页数:1
相关论文
共 47 条
  • [41] Circulating OxLDL-E06 levels reflect the presence and extent of angiographic coronary artery disease: Strong association between circulating oxidized phospholipids and Lp(a) may potentially mediate atherogenicity
    Tsimikas, S
    Brialkis, ES
    Miller, ER
    McConnell, JP
    Lennon, RJ
    Kornman, KS
    Witztum, JL
    Berger, PB
    CIRCULATION, 2004, 110 (17) : 182 - 183
  • [42] Gene Expression Profiling of Markers of Inflammation, Angiogenesis, Coagulation and Fibrinolysis in Patients with Coronary Artery Disease with Very High Lipoprotein(a) Levels Treated with PCSK9 Inhibitors
    Hrovat, Katja
    Likozar, Andreja Rehberger
    Zupan, Janja
    Sebestjen, Miran
    JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE, 2022, 9 (07)
  • [43] MARKED BENEFIT WITH SUSTAINED-RELEASE NIACIN THERAPY IN PATIENTS WITH ISOLATED VERY LOW-LEVELS OF HIGH-DENSITY-LIPOPROTEIN CHOLESTEROL AND CORONARY-ARTERY DISEASE
    LAVIE, CJ
    MAILANDER, L
    MILANI, RV
    AMERICAN JOURNAL OF CARDIOLOGY, 1992, 69 (12): : 1083 - 1085
  • [44] High-Throughput Measure of Mitochondrial Superoxide Levels as a Marker of Coronary Artery Disease to Accelerate Drug Translation in Patient-Derived Endothelial Cells Using Opera Phenix® Technology
    Lee, Weiqian E.
    Besnier, Marie
    Genetzakis, Elijah
    Tang, Owen
    Kott, Katharine A.
    Vernon, Stephen T.
    Gray, Michael P.
    Grieve, Stuart M.
    Kassiou, Michael
    Figtree, Gemma A.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (01)
  • [45] Lipoprotein-associated phospholipase A2 (Lp-PLA2) bound on high density lipoprotein is associated with lower risk of cardiac death in stable coronary artery disease patients: a three year follow-up
    Rallidis, L.
    Lekakis, J.
    Rizos, I.
    Tellis, C.
    Varounis, C.
    Barmperis, D.
    Charalampopoulos, A.
    Zolindaki, M.
    Anastasiou-Nana, M.
    Tselepis, A.
    EUROPEAN HEART JOURNAL, 2012, 33 : 784 - 784
  • [46] The WOMEN study: What is the optimal method for ischemia evaluation in women? A multi-center, prospective, randomized study to establish the optimal method for detection of coronary artery disease (CAD) risk in women at an intermediate-high pretest likelihood of CAD: study design
    Jennifer H. Mieres
    Leslee J. Shaw
    Robert C. Hendel
    Gary V. Heller
    Journal of Nuclear Cardiology, 2009, 16 : 105 - 112
  • [47] The WOMEN study: What is the optimal method for ischemia evaluation in women? A multi-center, prospective, randomized study to establish the optimal method for detection of coronary artery disease (CAD) risk in women at an intermediate-high pretest likelihood of CAD: study design
    Mieres, Jennifer H.
    Shaw, Leslee J.
    Hendel, Robert C.
    Heller, Gary V.
    JOURNAL OF NUCLEAR CARDIOLOGY, 2009, 16 (01) : 105 - 112